Entries by CAPTIS

Aytu BioScience to acquire Innovus Pharmaceuticals

This initial consideration to Innovus common shareholders is estimated to consist of approximately 4.2 million shares of Aytu stock. Additional consideration for up to $16 million in milestone The post Aytu BioScience to acquire Innovus Pharmaceuticals appeared first on Pharmaceutical Business review.